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LETTER TO THE EDITOR
PERCUTANEOUS ASPIRATION, LAVAGE AND
ANTIBIOTIC INSTILLATION
New Approach in the Management of Acute Cholecystitis
Failing to Respond to Conservative Management
Further to my recent publication in the Journal on the percutaneous management
of acute calculous cholecystitis1, I would like to communicate the results of a
prospective randomized study conducted at the Medical City in Baghdad, Iraq to
examine the role of percutaneous aspiration of the gallbladder followed by lavage
and antibiotic instillation into its lumen (500 mg ampicillin with 40 mg gentamicine,
PALA) when conservative management of acute cholecystitis appears to be failing.
Patients judged suitable for the study were those presenting with clinical signs
and symptoms (including a positive Murphy’s sign) of acute cholecystitis coupled
with pyrexia (more than 38 C), tachycardia, leucocytosis, normal serum amylase
levels and liver function tests, and ultrasonic evidence of a distended gallbladder
containing one or more stones. These patients were treated conservatively. They
were completely fasted, confined to bed, given 50 mg pethidine intramuscularly,
hydrated intravenously, allowed nil orally for at least 24 hours, and intravenously
treated with 1.2 grams of Augmentin (amoxycillin 1 g and clavulanic acid 200 mg,
Beecham Research Labs, Brentford, U.K.) every 8 hours. When this treatment
proved unsuccessful (failure of fever or tachycardia to show unequivocal evidence
of remission or of tenderness and rigidity to subside within 36 hours of beginning
nonoperative treatment), patients were fasted, their antibiotic stopped, and after
giving written informed consent, they were randomized by drawing sealed envel-
opes to have a standard cholecystostomy or PALA as previously described1.
Patients were not recruited if they were demented or moribund on admission, or
if they had evidence of septic shock; generalized peritonitis; jaundice; diabetes;
pregnancy; alcoholism; sensitivity to penicillins; hepatic, renal or any other serious
underlying disease; gastrointestinal disorders like reflux oesophagitis, hiatus her-
niation, peptic ulceration, the Zollinger-Ellison syndrome, Crohn’s disease, ulcer-
ative colitis, or the irritable bowel syndrome; any form of dissolution therapy for
cholelithiasis; lithotripsy; percutaneous cholecystolithotomy; previous gastrointes-
tinal surgery; concomitant treatment with any therapy to avoid pharmacological
effects of unknown origin; or regular use of analgesics and/or NSAIDs.
Furthermore, patients were not studied if ultrasonically the gallbladder was not
distended, contained no stones, if there was choledocholithiasis, or dilatation of the
biliary tree. At induction of anaesthesia, the cholecystostomy patients received
intravenously 2 grams cefotaxime with 500 mg metronidazole. The antibiotics
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instilled into the gallbladder of the PALA group (500 mg ampicillin and 40 mg
gentamicine) were also given intramuscularly in the mentioned doses 8 and 16
hours after the percutaneous procedure. Patients were excluded from efficacy
analysis because of failure to comply with the study design or because of using
analgesics and/or antispasmodics for abdominal pains. The remaining patients were
well matched regarding age, sex ratio, duration of symptoms at presentation (mean
in hours: cholecystostomy 11.2 and PALA 10.6) and length of complaints attrb
buted to gallstones (mean in months: cholecystostomy 5.3 and PALA 4.7). In 53
PALA patients (41 women and 12 men, age range 25 to 59 years, mean 36) and 50
cholecystostomy patients (40 women and 10 men, age range 22 to 59 years, mean
35) who were fully evaluable, both procedures were equally effective in controlling
the acute attack of cholecystitis within 24 hours, however PALA offered distinctive
gains. The procedure incurred no sepsis whereas cholecystostomy was associated
with chest infection in 3 patients (6%) and wound infection in 8 patients (16%).
PALA avoided an external biliary fistula and enabled a significantly (p < 0.001,
Mann-Whitney U test) earlier return to free fluids by mouth and then solid food
intake relative to cholecystostomy (3 hours vs 50 53 hours and 15 19 hours vs 56
61 hours, respectively). Consequently, the PALA patients were discharged from
hospital much sooner (p < 0.001) than the cholecystostomy cases (2 days vs 9 days
after the intervention). It was noted that the PALA procedure was very well
tolerated by all patients and caused no pain or discomfort. None of the patients
developed any visible evidence of infection at the site of needle entry and an
ultrasound scan carried out 48 hours after the percutaneous intervention showed no
evidence of right hypochondrial collection in any case. All the patients in both
groups remained asymptomatic until they underwent an elective cholecystectomy 6
weeks later.
Although in many surgical units early cholecystectomy for acute cholecystitis
comprises the standard of care and provides optimal therapy2’3’4, the morbidity and
mortality of this procedure particularly in patients who are over 50 years of age,
those with jaundice, the obese, and those who have a non-functioning gallbladder,
remain higher than those of elective surgery2’3. It would, thus, appear that
successful conservative management of acute cholecystitis to enable elective chole-
cystectomy to be carried out at a later date may reduce the overall morbidity and
mortality associated with this condition. When the conservative regimen fails to
control the acute episode of gallbladder inflammation, cholecystostomy is a simple
option not associated with the increased incidence of complications and the higher
death rate incurred by cholecystectomy under similar conditions. The acute
inflammatory process produces a distended gallbladder with its wall thickened and
engorged by active inflammation, which may be surrounded by dense vascular
adhesions and the adjacent liver tissue may be congested and friable. In such cases,
cholecystectomy carries the risk of haemorrhage which may occur both from
separated adhesions and from friable liver tissue. There is also a serious risk of
damage to the common bile duct and to the hepatic vessels, if they are obscured by
the inflammatory reaction or if there is any lack of experience on the part of the
operator. On the other hand, cholecystostomy has limitations in that it is not a
definitive procedure and should, therefore, be followed by an elective cholecystec-
tomy. Moreover, it prolongs hospital stay relative to cholecystectomy and produces
a higher incidence of wound infection5. The biliary fistula of cholecystostomy may
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nursing demands and additional costs, but also diverting some bile away from the
gastrointestinal tract, an event less suitable for normal metabolic activities. The
present investigation shows that PALA overcomes the disadvantages associated
with cholecystostomy for failure of conservative treatment of acute cholecystitis.
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